Clinical Trial Update: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

View source ↗

Summary

A clinical trial is investigating whether Galectin-3 levels predict outcomes in patients with renal cell carcinoma, urothelial carcinoma, non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Urothelial Carcinoma

Snippet

Sponsor: Daniel Keizman | Conditions: Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer | Status: RECRUITING